Spots Global Cancer Trial Database for dactinomycin
Every month we try and update this database with for dactinomycin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma | NCT02567435 | Alveolar Rhabdo... Botryoid-Type E... Embryonal Rhabd... Rhabdomyosarcom... Sclerosing Rhab... Spindle Cell Rh... | Cyclophosphamid... Dactinomycin Irinotecan Hydr... Laboratory Biom... Questionnaire A... Radiation Thera... Temsirolimus Vincristine Sul... Vinorelbine | - 40 Years | National Cancer Institute (NCI) | |
| Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma | NCT00072280 | Sarcoma | dactinomycin cyclophosphamid... etoposide ifosfamide vincristine sul... Conventional Su... MESNA (mercapto... Filgrastim | - 2 Years | Children's Oncology Group | |
| A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) | NCT06401330 | Stage I Kidney ... Stage II Kidney... Stage III Kidne... Stage IV Kidney... | Bone Scan Carboplatin Computed Tomogr... Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Magnetic Resona... Nephrectomy Patient Observa... Positron Emissi... Ultrasound Imag... Vincristine X-Ray Imaging | - 30 Years | Children's Oncology Group | |
| Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia | NCT00003688 | Gestational Tro... | dactinomycin | 12 Years - 50 Years | GOG Foundation | |
| Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | NCT00002610 | Kidney Cancer | dactinomycin filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... conventional su... radiation thera... | - 21 Years | Children's Oncology Group | |
| Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | NCT00047138 | Kidney Cancer | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 18 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor | NCT00379340 | Stage III Kidne... Stage IV Kidney... | 3-Dimensional C... Conventional Su... Cyclophosphamid... Dactinomycin Doxorubicin Hyd... Etoposide Vincristine Sul... | - 29 Years | Children's Oncology Group | |
| Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia | NCT01535053 | Choriocarcinoma FIGO Stage I Ge... FIGO Stage II G... FIGO Stage III ... Hydatidiform Mo... | Dactinomycin Leucovorin Calc... Methotrexate Quality-of-Life... | 18 Years - | GOG Foundation | |
| Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | NCT01014767 | Brain Cancer Choroid Plexus ... | Carboplatin Cisplatin Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Leucovorin Methotrexate Temozolomide Vincristine | - | Tufts Medical Center | |
| Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor | NCT00352534 | Stage I Kidney ... Stage II Kidney... Stage III Kidne... | 3-Dimensional C... Biospecimen Col... Chest Radiograp... Computed Tomogr... Dactinomycin Doxorubicin Hyd... Echocardiograph... Magnetic Resona... Therapeutic Con... Ultrasound Imag... Vincristine Sul... | - 29 Years | Children's Oncology Group | |
| Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | NCT00002610 | Kidney Cancer | dactinomycin filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... conventional su... radiation thera... | - 21 Years | Children's Oncology Group | |
| International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry | NCT01464606 | Pleuropulmonary... | Vincristine Dactinomycin Cyclophosphamid... Ifosfamide Doxorubicin | - 21 Years | Children's Hospitals and Clinics of Minnesota | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor | NCT00379340 | Stage III Kidne... Stage IV Kidney... | 3-Dimensional C... Conventional Su... Cyclophosphamid... Dactinomycin Doxorubicin Hyd... Etoposide Vincristine Sul... | - 29 Years | Children's Oncology Group | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | NCT00002995 | Sarcoma | dactinomycin filgrastim sargramostim cyclophosphamid... vincristine sul... radiation thera... | - 49 Years | Children's Oncology Group | |
| Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | NCT01014767 | Brain Cancer Choroid Plexus ... | Carboplatin Cisplatin Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Leucovorin Methotrexate Temozolomide Vincristine | - | Tufts Medical Center | |
| Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors | NCT00002489 | Extragonadal Ge... Ovarian Cancer | dactinomycin filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide leucovorin calc... methotrexate vincristine sul... conventional su... | - 20 Years | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | NCT00047138 | Kidney Cancer | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 18 Years | National Cancer Institute (NCI) | |
| Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | NCT04562558 | Gestational Tro... Gestational Tro... Stage I Gestati... Stage II Gestat... Stage III Gesta... Invasive Mole Choriocarcinoma | Methotrexate Leucovorin Dactinomycin | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma | NCT02567435 | Alveolar Rhabdo... Botryoid-Type E... Embryonal Rhabd... Rhabdomyosarcom... Sclerosing Rhab... Spindle Cell Rh... | Cyclophosphamid... Dactinomycin Irinotecan Hydr... Laboratory Biom... Questionnaire A... Radiation Thera... Temsirolimus Vincristine Sul... Vinorelbine | - 40 Years | National Cancer Institute (NCI) | |
| Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | NCT00025103 | Kidney Cancer | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide melphalan vincristine sul... autologous bone... conventional su... peripheral bloo... radiation thera... | - 17 Years | National Cancer Institute (NCI) | |
| Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | NCT01014767 | Brain Cancer Choroid Plexus ... | Carboplatin Cisplatin Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Leucovorin Methotrexate Temozolomide Vincristine | - | Tufts Medical Center | |
| Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer | NCT00002611 | Kidney Cancer | dactinomycin filgrastim cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... conventional su... radiation thera... | 0 Years - 15 Years | Children's Oncology Group | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | NCT00002995 | Sarcoma | dactinomycin filgrastim sargramostim cyclophosphamid... vincristine sul... radiation thera... | - 49 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | NCT00379457 | Sarcoma | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide topotecan hydro... vincristine sul... vinorelbine tar... conventional su... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity | NCT01323517 | Melanoma | Ipilimumab, Mel... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma | NCT00245141 | Sarcoma | dactinomycin cyclophosphamid... vincristine sul... radiation thera... | - 17 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors | NCT00002489 | Extragonadal Ge... Ovarian Cancer | dactinomycin filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide leucovorin calc... methotrexate vincristine sul... conventional su... | - 20 Years | Memorial Sloan Kettering Cancer Center | |
| Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma | NCT00245089 | Sarcoma | dactinomycin cyclophosphamid... vincristine sul... | - 17 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor | NCT00945009 | Adult Kidney Wi... Beckwith-Wiedem... Childhood Kidne... Diffuse Hyperpl... Rhabdoid Tumor ... Stage I Kidney ... Stage II Kidney... Stage III Kidne... Stage IV Kidney... Stage V Kidney ... | Dactinomycin Doxorubicin Hyd... Radiation Thera... Therapeutic Con... Vincristine Sul... | - 29 Years | Children's Oncology Group | |
| International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry | NCT01464606 | Pleuropulmonary... | Vincristine Dactinomycin Cyclophosphamid... Ifosfamide Doxorubicin | - 21 Years | Children's Hospitals and Clinics of Minnesota | |
| Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | NCT04562558 | Gestational Tro... Gestational Tro... Stage I Gestati... Stage II Gestat... Stage III Gesta... Invasive Mole Choriocarcinoma | Methotrexate Leucovorin Dactinomycin | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma | NCT00002766 | Leukemia Lymphoma | dactinomycin sargramostim carmustine cyclophosphamid... cytarabine daunorubicin hy... doxorubicin hyd... etoposide mercaptopurine methotrexate mitoxantrone hy... pegaspargase prednisone vincristine sul... radiation thera... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor | NCT00003804 | Kidney Cancer | dactinomycin vincristine sul... conventional su... | - 17 Years | National Cancer Institute (NCI) | |
| Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy | NCT01871766 | Rhabdomyosarcom... | Vincristine Dactinomycin Cyclophosphamid... Surgical Resect... Radiation Bevacizumab Sorafenib Myeloid Growth ... Lymph Node Samp... Irinotecan Ifosfamide Etoposide Etoposide Phosp... Doxorubicin Dexrazoxane ^1^1C-methionin... | - 21 Years | St. Jude Children's Research Hospital | |
| Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer | NCT00002611 | Kidney Cancer | dactinomycin filgrastim cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... conventional su... radiation thera... | 0 Years - 15 Years | Children's Oncology Group | |
| A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) | NCT06401330 | Stage I Kidney ... Stage II Kidney... Stage III Kidne... Stage IV Kidney... | Bone Scan Carboplatin Computed Tomogr... Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Magnetic Resona... Nephrectomy Patient Observa... Positron Emissi... Ultrasound Imag... Vincristine X-Ray Imaging | - 30 Years | Children's Oncology Group | |
| Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors | NCT00335556 | Childhood Renal... Clear Cell Rena... Clear Cell Sarc... Papillary Renal... Rhabdoid Tumor ... Stage I Renal C... Stage I Renal W... Stage II Renal ... Stage II Renal ... Stage III Renal... Stage III Renal... Stage IV Renal ... Stage IV Renal ... | Doxorubicin Hyd... Irinotecan Hydr... Conventional Su... Cyclophosphamid... Etoposide Carboplatin Dactinomycin Vincristine Sul... Radiation Thera... Laboratory Biom... | - 29 Years | Children's Oncology Group | |
| Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma | NCT00245141 | Sarcoma | dactinomycin cyclophosphamid... vincristine sul... radiation thera... | - 17 Years | National Cancer Institute (NCI) | |
| A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg | NCT04332874 | Sarcoma Myxofibrosarcom... Undifferentiate... Alveolar Soft P... | Isolated Limb I... Pembrolizumab infusion of mel... | 12 Years - | Memorial Sloan Kettering Cancer Center | |
| Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma | NCT00245089 | Sarcoma | dactinomycin cyclophosphamid... vincristine sul... | - 17 Years | National Cancer Institute (NCI) | |
| Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor | NCT00003804 | Kidney Cancer | dactinomycin vincristine sul... conventional su... | - 17 Years | National Cancer Institute (NCI) | |
| Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease | NCT06023641 | Rhabdomyosarcom... | Vincristine Dactinomycin Cyclophosphamid... Surgical Resect... Proton beam rad... Liposomal irino... Vinorelbine Temozolomide Filgrastim, peg... | - 22 Years | St. Jude Children's Research Hospital | |
| Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma | NCT00075582 | Adult Rhabdomyo... Embryonal Child... Embryonal-botry... Previously Untr... | conventional su... dactinomycin cyclophosphamid... vincristine sul... radiation thera... | - 49 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma | NCT00003958 | Adult Malignant... Adult Rhabdomyo... Alveolar Childh... Childhood Malig... Embryonal Child... Embryonal-botry... Nonmetastatic C... Previously Untr... Stage I Adult S... Stage II Adult ... Stage III Adult... | dactinomycin vincristine sul... cyclophosphamid... therapeutic con... radiation thera... topotecan hydro... filgrastim sargramostim laboratory biom... | - 49 Years | Children's Oncology Group | |
| GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) | NCT06309732 | Testicular Neop... | Pegfilgrastim Dactinomycin Methotrexate Etoposide Cisplatin Epirubicin | 16 Years - 35 Years | Queen Mary University of London | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | NCT00354835 | Adult Rhabdomyo... Childhood Alveo... Childhood Botry... Childhood Embry... Localized Child... Rhabdomyosarcom... Sarcoma Stage I Adult S... Stage II Adult ... Stage III Adult... | Cyclophosphamid... Dactinomycin Irinotecan Hydr... Laboratory Biom... Questionnaire A... Radiation Thera... Vincristine Sul... | - 49 Years | Children's Oncology Group | |
| High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | NCT00354744 | Sarcoma | dactinomycin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide irinotecan hydr... vincristine sul... conventional su... radiation thera... filgrastim | - 49 Years | Children's Oncology Group | |
| High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | NCT00354744 | Sarcoma | dactinomycin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide irinotecan hydr... vincristine sul... conventional su... radiation thera... filgrastim | - 49 Years | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
